Clinical Trial Update: Intravenous Gammaglobulin for Sickle Cell Pain Crises [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 clinical trials evaluating intravenous immunoglobulin for pain crises in sickle cell disease have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Sickle Cell Disease, Pain | Phase 1, Phase 2 | Status: COMPLETED